While ependymomas often have similar histologic features regardless of location, their molecular alterations are distinct with ZFTA and YAP1 fusions seen in supratentorial ependymomas and MYCN amplification in a subset of spinal ependymomas. The gene discussed is MYCN; the disease is ependymoma.